These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 21674174
21. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer. Li M, Zhao ZW. Med Oncol; 2012 Jun; 29(2):970-6. PubMed ID: 21660619 [Abstract] [Full Text] [Related]
22. Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma. Michailidi C, Theocharis S, Tsourouflis G, Pletsa V, Kouraklis G, Patsouris E, Papavassiliou AG, Troungos C. Exp Biol Med (Maywood); 2015 Dec; 240(12):1599-605. PubMed ID: 25908636 [Abstract] [Full Text] [Related]
23. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia. Seedhouse CH, Das-Gupta EP, Russell NH. Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664 [Abstract] [Full Text] [Related]
24. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma]. Xue HC, Wang JM, Xu B, Guo GP, Hua ZL, Zhou Q, Zhu ZH, Ma ZK, Gao J. Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989 [Abstract] [Full Text] [Related]
25. Correlation of chromosome damage and promoter methylation status of the DNA repair genes MGMT and hMLH1 in Chinese vinyl chloride monomer (VCM)-exposed workers. Wu F, Liu J, Qiu YL, Wang W, Zhu SM, Sun P, Miao WB, Li YL, Brandt-Rauf PW, Xia ZL. Int J Occup Med Environ Health; 2013 Mar; 26(1):173-82. PubMed ID: 23412991 [Abstract] [Full Text] [Related]
26. Review of the alterations in DNA methylation in esophageal squamous cell carcinoma. Baba Y, Watanabe M, Baba H. Surg Today; 2013 Dec; 43(12):1355-64. PubMed ID: 23291904 [Abstract] [Full Text] [Related]
27. Mismatch repair gene promoter methylation and expression in hydatidiform moles. Chen H, Ye D, Xie X, Lu W, Zhu C, Chen X. Arch Gynecol Obstet; 2005 Jun; 272(1):35-9. PubMed ID: 15338238 [Abstract] [Full Text] [Related]
28. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer. Jin J, Xie L, Xie CH, Zhou YF. Genet Mol Res; 2014 May 30; 13(2):4140-5. PubMed ID: 24938706 [Abstract] [Full Text] [Related]
29. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. Scott S, Kimura T, Ichinohasama R, Bergen S, Magliocco A, Reimer C, Kerviche A, Sheridan D, DeCoteau JF. Leuk Res; 2003 Jan 30; 27(1):23-34. PubMed ID: 12479849 [Abstract] [Full Text] [Related]
30. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa. Oue N, Sentani K, Yokozaki H, Kitadai Y, Ito R, Yasui W. Pathobiology; 2001 Jan 30; 69(3):143-9. PubMed ID: 11872960 [Abstract] [Full Text] [Related]
31. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma]. Zhang CJ, Li HM, Yau LM, Suen KW, Zhou GY, Yu F, Liew CT. Zhonghua Bing Li Xue Za Zhi; 2004 Oct 30; 33(5):433-6. PubMed ID: 15498213 [Abstract] [Full Text] [Related]
32. Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma. Lu C, Xie H, Wang F, Shen H, Wang J. BMC Cancer; 2011 Mar 05; 11():91. PubMed ID: 21375764 [Abstract] [Full Text] [Related]
33. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Zhang L, Lu W, Miao X, Xing D, Tan W, Lin D. Carcinogenesis; 2003 Jun 05; 24(6):1039-44. PubMed ID: 12807758 [Abstract] [Full Text] [Related]
34. Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes. Löf-Ohlin ZM, Nilsson TK. Oncol Rep; 2009 Mar 05; 21(3):721-9. PubMed ID: 19212632 [Abstract] [Full Text] [Related]
35. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Furlan D, Carnevali I, Marcomini B, Cerutti R, Dainese E, Capella C, Riva C. Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3329-36. PubMed ID: 16740754 [Abstract] [Full Text] [Related]
36. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. Alvarez MC, Santos JC, Maniezzo N, Ladeira MS, da Silva AL, Scaletsky IC, Pedrazzoli J, Ribeiro ML. World J Gastroenterol; 2013 May 28; 19(20):3043-51. PubMed ID: 23716983 [Abstract] [Full Text] [Related]
37. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients. Saikia S, Rehman AU, Barooah P, Sarmah P, Bhattacharyya M, Deka M, Deka M, Goswami B, Husain SA, Medhi S. Tumour Biol; 2017 May 28; 39(5):1010428317701630. PubMed ID: 28468586 [Abstract] [Full Text] [Related]
38. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma. Stark AM, Doukas A, Hugo HH, Hedderich J, Hattermann K, Maximilian Mehdorn H, Held-Feindt J. Neurol Res; 2015 Feb 28; 37(2):95-105. PubMed ID: 24995467 [Abstract] [Full Text] [Related]
39. Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma. Santos JC, Bastos AU, Cerutti JM, Ribeiro ML. BMC Cancer; 2013 Feb 15; 13():79. PubMed ID: 23414134 [Abstract] [Full Text] [Related]
40. Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India. Malhotra P, Anwar M, Kochhar R, Ahmad S, Vaiphei K, Mahmood S. Tumour Biol; 2014 Apr 15; 35(4):3679-87. PubMed ID: 24317816 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]